Fact CheckerSign in

NCT07625917Recruiting

Feasibility of Internet-based HIV Prevention Research

Source: ClinicalTrials.gov · Last updated 4 Jun 2026

Brief summary (registry, in English)

The study will use social media to recruit a diverse sample of people who self-report injecting drugs, assessing the feasibility of online assessments and participants' ability to perform at-home self-administered HIV testing. Participants will complete online questionnaires at baseline and will be mailed HIV testing kits that they will self-administer and mail to a central laboratory. Investigators will track completion of questionnaires and whether at-home self-administered HIV tests were completed and sent to the laboratory.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
500 (estimated)
First submitted
29 May 2026
Start date
1 Aug 2025
Primary completion date
29 May 2028
Lead sponsor
Montefiore Medical Center
Diseases
HIV
NCT number
NCT07625917

What you commit to

  • Study type: Interventional
  • Planned participants: 500
  • From 1 Aug 2025 to the primary completion date, 29 May 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • HIV status known to be positive

Who the study is looking for

  • 18 years or older
  • US residency
  • English or Spanish fluency
  • injection drug use (self-report, past 30 days)
  • basic reading comprehension

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Montefiore Medical Center
Coordinator of this site? Confirm its status
The BronxUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.